GRI
Price
$1.46
Change
+$0.06 (+4.29%)
Updated
Sep 3 closing price
Capitalization
3.67M
SLRX
Price
$4.80
Change
-$0.17 (-3.42%)
Updated
Sep 3 closing price
Capitalization
2.47M
Interact to see
Advertisement

GRI vs SLRX

Header iconGRI vs SLRX Comparison
Open Charts GRI vs SLRXBanner chart's image
GRI Bio
Price$1.46
Change+$0.06 (+4.29%)
Volume$47.6K
Capitalization3.67M
Salarius Pharmaceuticals
Price$4.80
Change-$0.17 (-3.42%)
Volume$45.8K
Capitalization2.47M
GRI vs SLRX Comparison Chart in %
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. SLRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Buy and SLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (GRI: $1.46 vs. SLRX: $4.80)
Brand notoriety: GRI and SLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 27% vs. SLRX: 20%
Market capitalization -- GRI: $3.67M vs. SLRX: $2.47M
GRI [@Biotechnology] is valued at $3.67M. SLRX’s [@Biotechnology] market capitalization is $2.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 2 FA rating(s) are green whileSLRX’s FA Score has 0 green FA rating(s).

  • GRI’s FA Score: 2 green, 3 red.
  • SLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, GRI is a better buy in the long-term than SLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 7 TA indicator(s) are bullish while SLRX’s TA Score has 5 bullish TA indicator(s).

  • GRI’s TA Score: 7 bullish, 2 bearish.
  • SLRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GRI is a better buy in the short-term than SLRX.

Price Growth

GRI (@Biotechnology) experienced а +2.10% price change this week, while SLRX (@Biotechnology) price change was -19.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRI($3.67M) has a higher market cap than SLRX($2.47M). SLRX YTD gains are higher at: -81.993 vs. GRI (-89.633). SLRX has more cash in the bank: 111M vs. GRI (5.12M). GRI has less debt than SLRX: GRI (96K) vs SLRX (112K).
GRISLRXGRI / SLRX
Capitalization3.67M2.47M149%
EBITDA-10.03MN/A-
Gain YTD-89.633-81.993109%
P/E Ratio0.02N/A-
Revenue0N/A-
Total Cash5.12M111M5%
Total Debt96K112K86%
FUNDAMENTALS RATINGS
GRI vs SLRX: Fundamental Ratings
GRI
SLRX
OUTLOOK RATING
1..100
217
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6598
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRI's Valuation (1) in the null industry is significantly better than the same rating for SLRX (88). This means that GRI’s stock grew significantly faster than SLRX’s over the last 12 months.

GRI's Profit vs Risk Rating (100) in the null industry is in the same range as SLRX (100). This means that GRI’s stock grew similarly to SLRX’s over the last 12 months.

GRI's SMR Rating (100) in the null industry is in the same range as SLRX (100). This means that GRI’s stock grew similarly to SLRX’s over the last 12 months.

GRI's Price Growth Rating (65) in the null industry is somewhat better than the same rating for SLRX (98). This means that GRI’s stock grew somewhat faster than SLRX’s over the last 12 months.

GRI's P/E Growth Rating (11) in the null industry is significantly better than the same rating for SLRX (100). This means that GRI’s stock grew significantly faster than SLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRISLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PZG1.070.02
+1.90%
Paramount Gold Nevada Corp
BENF0.38N/A
+0.13%
Beneficient
MBLY13.70-0.03
-0.22%
Mobileye Global
NIC135.94-0.54
-0.40%
Nicolet BanksharesInc
CLFD31.66-0.48
-1.49%
Clearfield

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with AMLX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
+4.29%
AMLX - GRI
57%
Loosely correlated
-1.40%
ATRA - GRI
40%
Loosely correlated
+2.35%
SNSE - GRI
38%
Loosely correlated
+10.57%
INAB - GRI
37%
Loosely correlated
+0.23%
SLRX - GRI
34%
Loosely correlated
-3.42%
More

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been loosely correlated with MBIO. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
-13.72%
MBIO - SLRX
64%
Loosely correlated
+1.32%
AMLX - SLRX
54%
Loosely correlated
+6.40%
PHIO - SLRX
41%
Loosely correlated
+7.61%
ATRA - SLRX
39%
Loosely correlated
+2.41%
AZTR - SLRX
35%
Loosely correlated
-9.16%
More